Clinical Trial Update: Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the Surefire Infusion Device in regional intra-arterial therapy for primary liver malignancies has been withdrawn. No final results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Surefire Infusion Device

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Liver Cancer | Phase 4 | Status: WITHDRAWN